Terminated NA INTERVENTIONAL 2-arm NCT00646971

Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea (SOREVAS)

Exhaled Markers of Oxidative Stress and Endothelium-dependent Vascular Relaxation in Obstructive Sleep Apnea. Effect of Continuous Positive Airway Pressure Therapy.

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Cardiovascular Risk Endothelial Dysfunction Intermittent Hypoxia Obstructive Sleep Apnea Syndrome Oxidative Stress

Interventions CPAP device Placebo device

Updated 5 times since 2017 Last updated: Jul 9, 2010 Started: Jan 31, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insuffisent recrutment

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

This NA trial investigates Cardiovascular Risk and Endothelial Dysfunction and is currently terminated or withdrawn. Assistance Publique - Hôpitaux de Paris leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clamart, France